19914686

Source:http://linkedlifedata.com/resource/pubmed/id/19914686

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0024115, umls-concept:C0035647, umls-concept:C0243077, umls-concept:C1456820
pubmed:issue	2
pubmed:dateCreated	2010-9-29
pubmed:abstractText	Tumor necrosis factor inhibitors (TNFi) are being increasingly used for a wide range of indications. There are increasing reports of pulmonary toxicity related to the use of TNFi. In this review, we have attempted to synthesize the available literature regarding noninfectious complications related to TNFi use.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/1306053
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1532-866X
pubmed:author	pubmed-author:CalabreseLeonard HLH, pubmed-author:KhasnisAtul AAA
pubmed:copyrightInfo	© 2010 Elsevier Inc. All rights reserved.
pubmed:issnType	Electronic
pubmed:volume	40
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	147-63
pubmed:meshHeading	pubmed-meshheading:19914686-Antirheumatic Agents, pubmed-meshheading:19914686-Databases, Factual, pubmed-meshheading:19914686-Humans, pubmed-meshheading:19914686-Lung Diseases, pubmed-meshheading:19914686-Rheumatic Diseases, pubmed-meshheading:19914686-Risk Factors, pubmed-meshheading:19914686-Tumor Necrosis Factor-alpha
pubmed:year	2010
pubmed:articleTitle	Tumor necrosis factor inhibitors and lung disease: a paradox of efficacy and risk.
pubmed:affiliation	Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, USA.
pubmed:publicationType	Journal Article, Review